Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-05

Clinical Trial Update: Exploring Renal Transplants Using Hepatitis C Infected Donors for HCV-negative Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial update on using Hepatitis C–infected donor kidneys for HCV-negative recipients has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Johns Hopkins University | Conditions: End-Stage Renal Disease, Hepatitis C | Phase 4 | Status: COMPLETED | Results posted: 2018-04-05